Literature DB >> 11343673

Effects of 1-year treatment with fluvastatin or pravastatin on bone.

S Watanabe1, S Fukumoto, Y Takeuchi, H Fujita, T Nakano, T Fujita.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11343673     DOI: 10.1016/s0002-9343(01)00679-9

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  11 in total

Review 1.  HMG CoA reductase inhibitors and the skeleton: a comprehensive review.

Authors:  D C Bauer
Journal:  Osteoporos Int       Date:  2003-05-08       Impact factor: 4.507

Review 2.  Hydroxymethylglutaryl-coenzyme A reductase inhibitors and osteoporosis: a meta-analysis.

Authors:  Christos Hatzigeorgiou; Jeffrey L Jackson
Journal:  Osteoporos Int       Date:  2005-03-03       Impact factor: 4.507

3.  Effects of simvastatin on bone mineral density and remodeling parameters in postmenopausal osteopenic subjects: 1-year follow-up study.

Authors:  Canan Tikiz; Hakan Tikiz; Fatma Taneli; Gül Gümüşer; Ciğdem Tüzün
Journal:  Clin Rheumatol       Date:  2005-03-02       Impact factor: 2.980

4.  Age-dependent effects of atorvastatin on biochemical bone turnover markers: a randomized controlled trial in postmenopausal women.

Authors:  Heiner K Berthold; Susanne Unverdorben; Armin Zittermann; Ralf Degenhardt; Bernhard Baumeister; Martin Unverdorben; Wilhelm Krone; Hans Vetter; Ioanna Gouni-Berthold
Journal:  Osteoporos Int       Date:  2004-02-14       Impact factor: 4.507

Review 5.  [Are statins of value in therapy of osteoporosis?].

Authors:  Markus Gosch
Journal:  Wien Med Wochenschr       Date:  2003

Review 6.  HMG-CoA reductase inhibitors in osteoporosis: do they reduce the risk of fracture?

Authors:  Raymond G Schlienger; Christoph R Meier
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

Review 7.  Are cardiovascular disease and osteoporosis directly linked?

Authors:  Crystal Whitney; Darren E R Warburton; Jiri Frohlich; Sammy Y Chan; Heather McKay; Karim Khan
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

Review 8.  The pleiotropic effects of HMG-CoA reductase inhibitors: their role in osteoporosis and dementia.

Authors:  Alla Waldman; Leonard Kritharides
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 9.  Fluvastatin for lowering lipids.

Authors:  Stephen P Adams; Sarpreet S Sekhon; Michael Tsang; James M Wright
Journal:  Cochrane Database Syst Rev       Date:  2018-03-06

10.  Osteogenesis and osteoclast inhibition in rheumatoid arthritis patients treated with bisphosphonates alone or in combination with pitavastatin over an 18-month follow-up after more than 4 years of treatment with bisphosphonates.

Authors:  Masakazu Nagashima; Hiroshi Takahashi; Kenichi Shimane; Yuichi Nagase; Koichi Wauke
Journal:  Arthritis Res Ther       Date:  2012-10-18       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.